Nature's Bioceuticals Set to Showcase Product Line at Premier Natural Products Trade Show
Botanical formula company will also present product at the annual Natural Products Association Marketplace as a new member of the organization
Cape Coral, FL- February 16, 2012
Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk - News) has confirmed its showcase of new products at the Natural Products Expo West Booth # 780. The annual natural, organic and healthy products trade show is set to take place March 9-11, 2012, at the Anaheim Convention Center in Anaheim, California.
“Nature’s Bioceuticals is honored and thrilled to be a part of Expo West this year,” began Robert deZanger, CEO of Nature’s Bioceuticals. “Our products are wonderful and effective all natural formulas that help provide proper bodily function for a number of common ailments. We feel there is no better outlet for showcasing our product line than this premier expo and trade show where all of the highest quality products will be shown to the most influential buyers in the industry.”
Nature’s Bioceuticals new line of all natural medicines are derived from botanicals and mineral bases with unique blends that help promote proper breathing function, sinus function , kidney function , prostate function , cold support, weight loss, as well as a number of new products yet to be announced.
Recently named as a new member of the Natural Products Association, the nation’s oldest and largest nonprofit organization dedicated to the natural products industry, Nature’s Bioceuticals will also have a showcase at the Natural Products Association Marketplace, the longest running natural and healthy products trade show, set to take place June 14-16, 2012, in Las Vegas, Nevada Booth #1315.
About Nature’s Bioceuticals
Nature’s Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature’s Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and, more importantly, do not have the negative side effects usually associated with many of today’s prescribed drugs.
Nature’s Bioceuticals line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA."
In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature’s Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature’s Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as “expects,” “intends,” “believes,” “anticipates,” “should,” “likely,” and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Neither Mistral Ventures, Inc. nor Nature’s Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company’s financial statements by the Company and its Audit Committee; modification of the Company’s accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
For more information about Nature’s Bioceuticals, visit www.naturesbioceuticals.com
Media Contact:
Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
